Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Unveils revamped brand identity.
March 19, 2026
By: Charlie Sternberg
Associate Editor
Esteve CDMO, a global pure-play CDMO specializing in small-molecule APIs and advanced pharmaceutical intermediates, has expanded its plans for the buildout of a new production unit at its facility in Celrà, and launched a new brand identity.
In parallel to its already-announced strategy to expand both production capacity and advanced containment capabilities with a new production unit in Celrà, the company has announced plans to add a further 3,000-square-meter production unit to accommodate additional spray drying equipment and services within purpose-built, high-potency containment suites.
The multi-year investment plans include a GEA Pharma-SD PSD-2 spray dryer, scheduled to be fully operational in the first quarter of 2027, followed by a new PSD-3, expected to come online late 2027. The new building includes space and the necessary infrastructure to include a commercial-scale PSD-4 spray dryer, and a further building project and a second PSD-4 are also planned.
These investments will strengthen ESTEVE CDMO’s ability to handle highly potent compounds safely and efficiently, while reinforcing its technological leadership in amorphous solid dispersion (ASD) solutions.
The company expects to add up to 15 new staff when PSD-2 and PSD-3 operations are fully underway, with PSD-4 operations planned to commence later.
“As our work in Girona progresses, it is important that we remain aligned with the needs of our partners, and adding spray drying capabilities can help solve problems they face with the characteristics of development pipelines, such as stability, poor solubility, potency, and scalability,” said Joan Petit, President at Esteve CDMO. “Proactive investment in our facilities helps us deliver on our vision to be a global CDMO leader in small molecule APIs that is trusted by partners for quality and reliability.”
At the same time, the company has announced its new Esteve CDMO brand, establishing a consistent global identity that allows it to establish a unique and distinctive persona, communicate the values that govern its corporate culture, and interact clearly and meaningfully with its stakeholders.
“Excellence is embedded in everything we do—it defines our mindset and guides our actions at every stage,” said Andrea Oro, Global Head of Commercial Operations and Strategy and Managing Director US at Esteve CDMO. “By truly listening, aligning, and collaborating with our partners, we transform our shared goal of improving lives together into a real outcome. That is what we call the science of collaboration.”
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !